Published online before print December 2, 2004, doi: 10.1161/01.RES.0000152325.07495.5a
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2005 American Heart Association, Inc.
Cellular Biology |
Connexin 43 Downregulation and Dephosphorylation in Nonischemic Heart Failure Is Associated With Enhanced Colocalized Protein Phosphatase Type 2A
From the Department of Medicine, University of Illinois at Chicago.
Correspondence to Steven M. Pogwizd, MD, Department of Medicine, University of Illinois at Chicago, 840 S Wood St, M/C 715, Chicago, IL 60612. E-mail spogwizd{at}uic.edu
In nonischemic heart failure (HF), ventricular tachycardia initiates by a nonreentrant mechanism, but there is altered conduction (that could lead to re-entry) that could arise from changes in gap junctional proteins, especially connexin43 (Cx43). We studied Cx43 expression and phosphorylation state in the left ventricle (LV) from an arrhythmogenic rabbit model of nonischemic HF and from patients with HF attributable to idiopathic dilated cardiomyopathy. We also investigated the role of protein phosphatases that dephosphorylate Cx43—PP1 and PP2A. In HF rabbit LV, Cx43 mRNA and total protein were decreased by 29% and 34%, respectively (P<0.05 and P<0.001). In controls, Cx43 was primarily in the phosphorylated state, but with HF there was a 64% increase in nonphosphorylated Cx43 (Cx43-NP, normalized to total Cx43; P<0.05). Similar results were noted in HF rabbit myocytes (P<0.05) and in human idiopathic dilated cardiomyopathy LV (P<0.05). We found that PP1 and PP2A colocalized with Cx43 in rabbit LV. With HF, the level of colocalized PP2A increased >2.5-fold (P<0.002), whereas colocalized PP1 was unchanged. We also found intercellular coupling (assessed by Lucifer Yellow dye transfer) was markedly reduced in HF. However, okadaic acid (10 nmol/L) reduced the amount of Cx43-NP and significantly improved cell coupling in HF. Thus, in nonischemic HF in rabbits and humans, there is a decrease in both Cx43 expression and phosphorylation that contributes to uncoupling. Increased levels of PP2A that colocalize with Cx43 can underlie enhanced levels of Cx43-NP in HF. Modulation of Cx43 phosphorylation may be a potential therapeutic target to improve conduction in HF.
Key Words: gap junctions • phosphorylation • phosphatases • heart failure • arrhythmia
This article has been cited by other articles:
 |
|
 |
|
  E. I. Rossman, K. Liu, G. A. Morgan, R. E. Swillo, J. A. Krueger, S. J. Gardell, J. Butera, M. Gruver, J. Kantrowitz, H. S. Feldman, et al. The Gap Junction Modifier, GAP-134 [(2S,4R)-1-(2-Aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic Acid], Improves Conduction and Reduces Atrial Fibrillation/Flutter in the Canine Sterile Pericarditis Model J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 1127 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Bupha-Intr, K. M. Haizlip, and P. M. L. Janssen Temporal changes in expression of connexin 43 after load-induced hypertrophy in vitro Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H806 - H814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Hund, P. J. Wright, W. Dun, J. S. Snyder, P. A. Boyden, and P. J. Mohler Regulation of the ankyrin-B-based targeting pathway following myocardial infarction Cardiovasc Res, March 1, 2009; 81(4): 742 - 749. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Qu, F. M. Volpicelli, L. I. Garcia, N. Sandeep, J. Zhang, L. Marquez-Rosado, P. D. Lampe, and G. I. Fishman Gap Junction Remodeling and Spironolactone-Dependent Reverse Remodeling in the Hypertrophied Heart Circ. Res., February 13, 2009; 104(3): 365 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Totzeck, K. Boengler, A. van de Sand, I. Konietzka, P. Gres, D. Garcia-Dorado, G. Heusch, and R. Schulz No impact of protein phosphatases on connexin 43 phosphorylation in ischemic preconditioning Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2106 - H2112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sato, T. Ohkusa, H. Honjo, S. Suzuki, M.-a. Yoshida, Y. S. Ishiguro, H. Nakagawa, M. Yamazaki, M. Yano, I. Kodama, et al. Altered expression of connexin43 contributes to the arrhythmogenic substrate during the development of heart failure in cardiomyopathic hamster Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1164 - H1173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-A. Meilleur, C. D. Akpovi, R.-M. Pelletier, and M. L. Vitale Tumor Necrosis Factor-{alpha}-Induced Anterior Pituitary Folliculostellate TtT/GF Cell Uncoupling Is Mediated by Connexin 43 Dephosphorylation Endocrinology, December 1, 2007; 148(12): 5913 - 5924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Lurtz and C. F. Louis Purinergic Receptor Mediated Regulation of Lens Connexin43 Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4177 - 4186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. G. Akar, R. D. Nass, S. Hahn, E. Cingolani, M. Shah, G. G. Hesketh, D. DiSilvestre, R. S. Tunin, D. A. Kass, and G. F. Tomaselli Dynamic changes in conduction velocity and gap junction properties during development of pacing-induced heart failure Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1223 - H1230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. S. Kasi, H. D. Xiao, L. L. Shang, S. Iravanian, J. Langberg, E. A. Witham, Z. Jiao, C. J. Gallego, K. E. Bernstein, and S. C. Dudley Jr. Cardiac-restricted angiotensin-converting enzyme overexpression causes conduction defects and connexin dysregulation Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H182 - H192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Bhasin, S. R. Cunha, M. Mudannayake, M. S. Gigena, T. B. Rogers, and P. J. Mohler Molecular basis for PP2A regulatory subunit B56{alpha} targeting in cardiomyocytes Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H109 - H119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nattel, A. Maguy, S. Le Bouter, and Y.-H. Yeh Arrhythmogenic Ion-Channel Remodeling in the Heart: Heart Failure, Myocardial Infarction, and Atrial Fibrillation Physiol Rev, April 1, 2007; 87(2): 425 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Shiroshita-Takeshita, M. Sakabe, K. Haugan, J. K. Hennan, and S. Nattel Model-Dependent Effects of the Gap Junction Conduction-Enhancing Antiarrhythmic Peptide Rotigaptide (ZP123) on Experimental Atrial Fibrillation in Dogs Circulation, January 23, 2007; 115(3): 310 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Valencik, D. Zhang, B. Punske, P. Hu, J. A. McDonald, and S. E. Litwin Integrin Activation in the Heart: A Link Between Electrical and Contractile Dysfunction? Circ. Res., December 8, 2006; 99(12): 1403 - 1410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Eltzschig, T. Eckle, A. Mager, N. Kuper, C. Karcher, T. Weissmuller, K. Boengler, R. Schulz, S. C. Robson, and S. P. Colgan ATP Release From Activated Neutrophils Occurs via Connexin 43 and Modulates Adenosine-Dependent Endothelial Cell Function Circ. Res., November 10, 2006; 99(10): 1100 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rucker-Martin, P. Milliez, S. Tan, X. Decrouy, M. Recouvreur, R. Vranckx, C. Delcayre, J.-F. Renaud, I. Dunia, D. Segretain, et al. Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts Cardiovasc Res, October 1, 2006; 72(1): 69 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Snabaitis, R. D'Mello, S. Dashnyam, and M. Avkiran A Novel Role for Protein Phosphatase 2A in Receptor-mediated Regulation of the Cardiac Sarcolemmal Na+/H+ Exchanger NHE1 J. Biol. Chem., July 21, 2006; 281(29): 20252 - 20262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Ai, J. W. Curran, T. R. Shannon, D. M. Bers, and S. M. Pogwizd Ca2+/Calmodulin-Dependent Protein Kinase Modulates Cardiac Ryanodine Receptor Phosphorylation and Sarcoplasmic Reticulum Ca2+ Leak in Heart Failure Circ. Res., December 9, 2005; 97(12): 1314 - 1322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Spragg and D. A. Kass Controlling the Gap: Myocytes, Matrix, and Mechanics Circ. Res., March 18, 2005; 96(5): 485 - 487. [Full Text] [PDF]
|
|